CDK2 (NM_001798) Human Recombinant Protein
CAT#: TP300494
Recombinant protein of human cyclin-dependent kinase 2 (CDK2), transcript variant 1
USD 447.00
Specifications
| Product Data | |
| Species | Human |
| Expression Host | HEK293T |
| Expression cDNA Clone or AA Sequence |
>RC200494 protein sequence
Red=Cloning site Green=Tags(s) MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA LAHPFFQDVTKPVPHLRL TRTRPLEQKLISEEDLAANDILDYKDDDDKV |
| Tag | C-Myc/DDK |
| Predicted MW | 33.7 kDa |
| Concentration | >50 ug/mL as determined by microplate BCA method |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
| Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
| Note | For culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process. |
| Storage | Store at -80°C. |
| Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Reference Data | |
| RefSeq | NP_001789 |
| Locus ID | 1017 |
| UniProt ID | P24941, A0A024RB77 |
| Cytogenetics | 12q13.2 |
| Refseq Size | 2301 |
| Refseq ORF | 894 |
| Synonyms | CDKN2; p33(CDK2) |
| Summary | This gene encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. The encoded protein is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014] |
| Protein Families | Druggable Genome, Protein Kinase |
| Protein Pathways | Cell cycle, Oocyte meiosis, p53 signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Small cell lung cancer |
Documents
| FAQs |
| SDS |
Resources
Recombinant Protein Resources |
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| LC409442 | CDK2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LC419741 | CDK2 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LY409442 | Transient overexpression lysate of cyclin-dependent kinase 2 (CDK2), transcript variant 2 |
USD 436.00 |
|
| LY419741 | Transient overexpression lysate of cyclin-dependent kinase 2 (CDK2), transcript variant 1 |
USD 436.00 |
|
| PH300494 | CDK2 MS Standard C13 and N15-labeled recombinant protein (NP_001789) |
USD 2,055.00 |
|
| TP720187 | Recombinant protein of human cyclin-dependent kinase 2 (CDK2), transcript variant 1 |
USD 330.00 |
{0} Product Review(s)
Be the first one to submit a review
Germany
Japan
United Kingdom
China